Clinical Trials Directory

Trials / Completed

CompletedNCT07116993

Effects of Ultrasound and Infrared on Joint Pain and Movement in Hemophilia A Patients.

Comparative Effects of Ultrasound and Infrared on Pain, Range of Motion and Joint Health in Knee, Elbow and Ankle Joints in Patients With Hemophilia A: a Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Danyal Ahmad · Academic / Other
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

The study aims to compare the effectiveness of therapeutic ultrasound and infrared in managing hemarthrosis in patients with Hemophilia A, focusing on specific outcomes like joint pain, swelling, muscle atrophy, and range of motion.The main question to it is either one from both of the modalities are effective for hemophilia patients or not? comparison will be done to check the effectiveness of ultrasound and infrared on patients of both groups. participants will: 1. get the treatment according to their respective groups 2. Both groups were given 4 sessions for 4 weeks.

Detailed description

The data collection was started by the consent of the participants through the consent form. Then we randomly divided the patients into Group A and Group B. Group A participants were given Ultrasound therapy for 10 minutes with intensity of 1.5 W/m2 along with the conventional physiotherapy as well as home plan. Group B participants were given Infrared therapy for 10 minutes with moderate intensity along with the conventional physiotherapy as well as home plan. Both groups were given 4 sessions for 4 weeks.

Conditions

Interventions

TypeNameDescription
DEVICEtheraputic ultrasoundUltrasound is a mechanical sound wave with frequencies above human hearing, requiring a medium like air or tissue to travel, commonly used in imaging.
DEVICEinfrared radiationInfrared, in contrast, is electromagnetic radiation associated with heat, doesn't need a medium, and is used in applications like thermal imaging and remote controls.

Timeline

Start date
2024-03-01
Primary completion
2024-03-30
Completion
2024-06-15
First posted
2025-08-12
Last updated
2025-08-12

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07116993. Inclusion in this directory is not an endorsement.